Isabelle Maystadt

Prof. Isabelle Maystadt

Institut de Pathologie et de Génétique
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
AGAnne Gregor
Anne Gregor
BABeate Albrecht
Beate Albrecht
IBIngrid Bader
Ingrid Bader
EBEmilia K Bijlsma
Emilia K Bijlsma
AEArif B Ekici
Arif B Ekici
CZChristiane Zweier
Christiane Zweier
Background: Heterozygous copy-number and missense variants inCNTNAP2andNRXN1have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous defects in either gene were reported as causative for severe intellectual disability.Methods: 99 patients with severe intellectual disability and resemblance to Pitt-Hopkins syndrome and/or suspected recessive inheritance were screened for mutations inCNTNAP2andNRXN1. Molecular karyotyping was performed in 45 patients. In 8 further patients with variable intellectual disability and heterozygous deletions in eitherCNTNAP2orNRXN1, the remaining allele was sequenced.Results: By molecular karyotyping and mutational screening ofCNTNAP2andNRXN1in a group of severely intellectually disabled patients we identified a heterozygous deletion inNRXN1in one patient and heterozygous splice-site, frameshift and stop mutations inCNTNAP2in four patients, respectively. Neither in these patients nor in eight further patients with heterozygous deletions withinNRXN1orCNTNAP2we could identify a defect on the second allele. One deletion inNRXN1and one deletion inCNTNAP2occurredde novo, in another family the deletion was also identified in the mother who had learning difficulties, and in all other tested families one parent was shown to be healthy carrier of the respective deletion or mutation.Conclusions: We report on patients with heterozygous defects inCNTNAP2orNRXN1associated with severe intellectual disability, which has only been reported for recessive defects before. These results expand the spectrum of phenotypic severity in patients with heterozygous defects in either gene. The large variability between severely affected patients and mildly affected or asymptomatic carrier parents might suggest the presence of a second hit, not necessarily located in the same gene.

1 July 2007 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
IMIsabelle Maystadt
Isabelle Maystadt
RRRené Rezsöhazy
René Rezsöhazy
MBMartine Barkats
Martine Barkats
SDSandra Duque
Sandra Duque
PVPascal Vannuffel
Pascal Vannuffel
CVChristine Verellen-Dumoulin
Christine Verellen-Dumoulin

21 July 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
LLLorenzo Loberti
Lorenzo Loberti
LBLucia Bruno
Lucia Bruno
SGStefania Granata
Stefania Granata
GDGabriella Doddato
Gabriella Doddato
SRSara Resciniti
Sara Resciniti
APAnna Maria Pinto
Anna Maria Pinto
KBG syndrome (KBGS) is characterized by distinctive facial gestalt, short stature and variable clinical findings. With ageing, some features become more recognizable, allowing a differential diagnosis. We aimed to better characterize natural history of KBGS. In the context of a European collaborative study, we collected the largest cohort of KBGS patients (49). A combined array- based Comparative Genomic Hybridization and next generation sequencing (NGS) approach investigated both genomic Copy Number Variants and SNVs. Intellectual disability (ID) (82%) ranged from mild to moderate with severe ID identified in two patients. Epilepsy was present in 26.5%. Short stature was consistent over time, while occipitofrontal circumference (median value: −0.88 SD at birth) normalized over years. Cerebral anomalies, were identified in 56% of patients and thus represented the second most relevant clinical feature reinforcing clinical suspicion in the paediatric age when short stature and vertebral/dental anomalies are vague. Macrodontia, oligodontia and dental agenesis (53%) were almost as frequent as skeletal anomalies, such as brachydactyly, short fifth finger, fifth finger clinodactyly, pectus excavatum/carinatum, delayed bone age. In 28.5% of individuals, prenatal ultrasound anomalies were reported. Except for three splicing variants, leading to a premature termination, variants were almost all frameshift. Our results, broadening the spectrum of KBGS phenotype progression, provide useful tools to facilitate differential diagnosis and improve clinical management. We suggest to consider a wider range of dental anomalies before excluding diagnosis and to perform a careful odontoiatric/ear-nose-throat (ENT) evaluation in order to look for even submucosal palate cleft given the high percentage of palate abnormalities. NGS approaches, following evidence of antenatal ultrasound anomalies, should include ANKRD11.

Verified
Journal Article
Open access
PDF file
ECElisa Colombo
Elisa Colombo
ALAndrea Locatelli
Andrea Locatelli
LSLaura Cubells Sánchez
Laura Cubells Sánchez
SSara Romeo
Sara Romeo
NENursel Elcioglu
Nursel Elcioglu
Lidia LarizzaLidia Larizza
Lidia Larizza
Biallelic mutations in RECQL4 gene, a caretaker of the genome, cause Rothmund-Thomson type-II syndrome (RTS-II) and confer increased cancer risk if they damage the helicase domain. We describe five families exemplifying clinical and allelic heterogeneity of RTS-II, and report the effect of pathogenic RECQL4 variants by in silico predictions and transcripts analyses. Complete phenotype of patients #39 and #42 whose affected siblings developed osteosarcoma correlates with their c.[1048_1049del], c.[1878+32_1878+55del] and c.[1568G>C;1573delT], c.[3021_3022del] variants which damage the helicase domain. Literature survey highlights enrichment of these variants affecting the helicase domain in patients with cancer outcome raising the issue of strict oncological surveillance. Conversely, patients #29 and #19 have a mild phenotype and carry, respectively, the unreported homozygous c.3265G>T and c.3054A>G variants, both sparing the helicase domain. Finally, despite matching several criteria for RTS clinical diagnosis, patient #38 is heterozygous for c.2412_2414del; no pathogenic CNVs out of those evidenced by high-resolution CGH-array, emerged as contributors to her phenotype.

2 February 2016 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
SBSamuel Balbeur
Samuel Balbeur
BGBernard Grisart
Bernard Grisart
BPBenoit Parmentier
Benoit Parmentier
DSDaniel Sartenaer
Daniel Sartenaer
PLPierre‐Emmanuel Leonard
Pierre‐Emmanuel Leonard
IMIsabelle Maystadt
Isabelle Maystadt
Key Clinical Message: Maternal uniparental disomy of chromosome 14 (upd(14)mat) is responsible for a Prader–Willi‐like syndrome with precocious puberty. Although upd(14) is often hypothesized to result from trisomy rescue mechanism, T14 cell lines are usually not found with postnatal cytogenetic investigations. We report the coexistence of both chromosomal abnormalities in a 15‐year‐old girl.

17 August 2021 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SDSarah Duerinckx
Sarah Duerinckx
JDJulie Désir
Julie Désir
CPCamille Perazzolo
Camille Perazzolo
CBCindy Badoer
Cindy Badoer
VJValérie Jacquemin
Valérie Jacquemin
MAMarc Abramowicz
Marc Abramowicz
Background: Primary microcephaly (PM) is defined as a significant reduction in occipitofrontal circumference (OFC) of prenatal onset. Clinical and genetic heterogeneity of PM represents a diagnostic challenge.Methods: We performed detailed phenotypic and genomic analyses in a large cohort (n = 169) of patients referred for PM and could establish a molecular diagnosis in 38 patients.Results: Pathogenic variants in ASPM and WDR62 were the most frequent causes in non‐consanguineous patients in our cohort. In consanguineous patients, microarray and targeted gene panel analyses reached a diagnostic yield of 67%, which contrasts with a much lower rate in non‐consanguineous patients (9%). Our series includes 11 novel pathogenic variants and we identify novel candidate genes including IGF2BP3 and DNAH2. We confirm the progression of microcephaly over time in affected children. Epilepsy was an important associated feature in our PM cohort, affecting 34% of patients with a molecular confirmation of the PM diagnosis, with various degrees of severity and seizure types.Conclusion: Our findings will help to prioritize genomic investigations, accelerate molecular diagnoses, and improve the management of PM patients.